ArticleTherapeutic innovation & regulatory science2026
Patient-Reported Outcomes Used for Regulatory Approval of Medicines Indicated for the Treatment of Dermatological Diseases Authorized in the European Union Between 1998 and 2024.
Eléonore Coenen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.